Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 14, 2017; 23(14): 2453-2458
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2453
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2453
Ref. | Reference standard | Sensitivity | Specificity | Clarithromycin resistance |
Scaletsky et al[32] | PCR on gastric biopsy | 83.3% | 100.0% | 26.7% |
1Vécsei et al[38] | Culture | 89.2% | 100.0% | 45.1% |
Noguchi et al[33] | Culture | NA | NA | 20.4% |
Rimbara et al[34] | Culture | 96.6% | 91.3% | 13.3% |
1Booka et al[35] | Culture | NA | NA | 31.0% |
Schabereiter-Gurtner et al[36] | Culture | 98.0% | 98.0% | 24.4% |
Fontana et al[37] | Culture | 100.0% | 100.0% | 1.6% |
- Citation: Ierardi E, Giorgio F, Iannone A, Losurdo G, Principi M, Barone M, Pisani A, Di Leo A. Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy? World J Gastroenterol 2017; 23(14): 2453-2458
- URL: https://www.wjgnet.com/1007-9327/full/v23/i14/2453.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i14.2453